4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Hoobkas
Chaw tsim khoom, siab purity, coj mus muag ntau lawm
Lub npe tshuaj: 4-Aminopyridine
CAS: 504-24-5 Nr
Tshuaj npe | 4-Aminopyridine |
Synonyms | 4-AP;4-Pyridinamine;Fampridine;Dalfampridine;p-Aminopyridine;γ-Aminopyridine |
CAS Nr | 504-24-5 : kuv |
CAT Number | Qauv Zauv: RF-PI539 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C5H6N 2 |
Molecular Luj | 94.12 ib |
Solubility | Soluble hauv dej, Ethanol |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb los yog me ntsis daj crystalline hmoov |
Assay / Analysis Method | ≥99.5% (HPLC) |
Melting Point | 157.0 ~ 162.0 ℃ |
Dej (KF) | ≤0.50% |
Sulfated tshauv | ≤ 0.20% |
2-Aminopyridine | ≤0.10% |
3-Aminopyridine | ≤0.10% |
Tag nrho cov impurities | ≤0.50% |
Test Standard | Enterprise Standard |
Kev siv | Pharmaceutical Intermediates;API |
Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo.
![1](https://www.ruifuchemical.com/uploads/15.jpg)
![](https://www.ruifuchemical.com/uploads/23.jpg)
4-Aminopyridine (CAS: 504-24-5) yog ib qho ntawm peb lub isomeric amines ntawm pyridine, yog ib qho ntshiab, hluavtaws, thiab cov khoom siv lom neeg lom neeg, dav siv hauv cov organic synthesis, synthesis ntawm cov tshuaj intermediates thiab Active Pharmaceutical Ingredient (API ) synthesis.4-Aminopyridine (4-AP, Fampridine, Dalfampridine) yog siv los ua cov cuab yeej tshawb fawb hauv kev ua tus yam ntxwv ntawm cov kab mob potassium.Nws kuj tau siv los ua tshuaj, los tswj qee cov tsos mob ntawm ntau yam sclerosis, thiab tau qhia rau kev txhim kho cov tsos mob ntawm kev taug kev hauv cov neeg laus nrog ntau yam kev hloov pauv ntawm tus kab mob.Lub US Food and Drug Administration (FDA) tau pom zoo cov khoom sib xyaw rau lub Ib Hlis 22, 2010. Fampridine kuj tau muag hauv Tebchaws Meskas los ntawm Acorda Therapeutics thiab ua Fampyra hauv European Union, Canada, thiab Australia.